Certified by Founder Lodge
Venrock
United States - Palo Alto, CA
INVESTOR
1 Disclosed Funding Rounds $40,000,000
28 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Venrock partners with entrepreneurs who want to tackle big, hard problems that most think not possible. For more information, please visit www.venrock.com or follow the firm on Twitter at @Ve
Company | Date | Round | Raised |
---|---|---|---|
Quiq | April, 12 ,2022 | Series C | $25,000,000 |
Nightfall AI | August, 10 ,2022 | Series B | $40,000,000 |
Astronomer | March, 23 ,2022 | Series C | $213,000,000 |
Dgraph Labs | July, 20 ,2022 | Seed | $6,000,000 |
Quiq | April, 12 ,2022 | Series C | $25,000,000 |
Zero Networks | February, 22 ,2022 | Series A | $20,300,000 |
Astronomer | March, 23 ,2022 | Series C | $213,000,000 |
Decodable | February, 24 ,2022 | Series A | $20,000,000 |
Zero Networks | February, 22 ,2022 | Series A | $20,300,000 |
Airspeed | May, 08 ,2023 | Unknown | $7,500,000 |
Decodable | February, 24 ,2022 | Series A | $20,000,000 |
ADARx Pharmaceuticals Inc. | August, 10 ,2023 | Series C | $200,000,000 |
Airspeed | May, 08 ,2023 | Unknown | $7,500,000 |
Moment | September, 18 ,2023 | Series A | $17,000,000 |
ADARx Pharmaceuticals Inc. | August, 10 ,2023 | Series C | $200,000,000 |
RefleXion Medical | November, 17 ,2023 | Unknown | $105,000,000 |
Moment | September, 18 ,2023 | Series A | $17,000,000 |
Accompany Health | February, 01 ,2024 | Series A | $56,000,000 |
RefleXion Medical | November, 17 ,2023 | Unknown | $105,000,000 |
Archetype AI | April, 08 ,2024 | Seed | $13,000,000 |
Accompany Health | February, 01 ,2024 | Series A | $56,000,000 |
Tembo(US) | July, 03 ,2024 | Series A | $14,000,000 |
Archetype AI | April, 08 ,2024 | Seed | $13,000,000 |
Tembo(US) | July, 03 ,2024 | Series A | $14,000,000 |
Element Biosciences | July, 12 ,2024 | Series D | $277,000,000 |
Element Biosciences | July, 12 ,2024 | Series D | $277,000,000 |
Candid Therapeutics | September, 10 ,2024 | Unknown | $370,000,000 |
Metsera | November, 14 ,2024 | Series B | $215,000,000 |